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ABSTRACT 
 
Objectives: To determine what obstetric complications can be associated with 
end-stage AIDS and maternal death.  
 
Method: From 1990 to 2005 the maternal death files of patients with either 
AIDS-defining illnesses or CD4 counts of less than 200x106/ℓ were analyzed in 
a descriptive study. All patients died undelivered or within 42 days of delivery.  
 
Result: Sixty six percent (49/74) of pregnancies ended prematurely by preterm 
delivery or miscarriage. Twenty perinatal deaths occurred. The average birth 
weight was 1498g at an average gestational age of 30.5 weeks. The mean 
CD4 count was 45.5x106/ℓ. The majority of maternal deaths were caused by 
respiratory illnesses.  
 
Conclusion: Preterm labour and early pregnancy loss are common among 
terminally ill pregnant women with AIDS. It is proposed that hypoxia in the 
presence of respiratory disease could lead to cytokine production in the uterine 
cavity, leading to preterm delivery, even in the absence of intrauterine 
infection. 
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1. Introduction 
 
 With increasing prevalence of the Human Immunodeficiency Virus (HIV) 
infection in the general population of South Africa, it is only natural that acquired 
immunodeficiency syndrome (AIDS) related disease is becoming more common 
in the hospital environment. This is also true for the maternity hospital. The World 
Health Organization (WHO) figures indicate that the majority of the world’s HIV 
positive population can be found in sub-Saharan Africa. By 2000, over 33.6 
million people worldwide were estimated to be infected with HIV and an 
estimated 23.3 million of them were living in sub-Saharan Africa (over 50%) [1]. 
South Africa in particular is faced with an increasing number of HIV positive 
women and HIV positive pregnant women [1].  
 
The South African Confidential Enquiries into Maternal Deaths of 1999-2001, 
found AIDS to be the leading cause of maternal death in South Africa [2].  In the 
more recent Saving Mothers Report (2002 – 2004) [3], it was reported that the 
four main causes of maternal death from 2002 to 2004 in the category of non-
pregnancy related infection were AIDS (20.1%), pneumonia (9.6%), tuberculosis 
(3.2%) and meningitis (2.4%).  
 
Recently, in South Africa, a programme has been launched to provide HIV 
positive patients with antiretroviral drugs. This programme may improve general 
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health of infected patients, as well as prolong their lives. This again, might cause 
a decrease in AIDS-related maternal deaths. 
 
Infection with HIV may result in a spectrum of diseases, many of them poorly 
understood. It therefore becomes difficult to identify which complications during 
pregnancy should be attributed to the virus and which not. In the early stages of 
the disease, the pregnant patient is virtually unaffected and perinatal outcomes 
are comparable with the general population [4]. 
 
Medical staff at Chris Hani Baragwanath Hospital have observed that end-stage 
AIDS is associated with certain obstetric complications. A frequent occurrence is 
that a dying HIV positive mother presents with spontaneous preterm labour and 
gives birth to a small, often dead fetus, before she herself passes on. The 
mechanism for this is unclear, but may be related to severe infection with 
production and circulation of cytokines which induce labour [5]. 
 
The objective of this study was to establish whether there is a trend towards 
certain obstetric complications among terminally ill pregnant patients with AIDS 
and to see whether there is an association between their AIDS-related conditions 
and the obstetric complications. The obstetric outcomes of interest were 
intrauterine fetal death and spontaneous preterm labour. This study may help to 
improve understanding of illness and mortality. 
 3 
2. Literature review 
 
In the sections to follow, literature will be discussed as a prelude to the findings 
of the study. Special attention will be paid to AIDS and HIV infection, as well as 
management of the epidemic in the South African setting. 
 
2.1 Preterm labour 
It has been suggested that preterm labour occurs secondary to infection of the 
amniotic fluid, membranes and placenta. This may associated with HIV infection. 
At the United Arab Emirates Government Hospital in Manipur, India, 153 
placentas were preserved in formalin and samples taken from the membranes as 
well, after postpartum expulsion. The specimens were processed and stained 
with haematoxylin-eosin. The sections were then examined for histological 
evidence of inflammation. It was found that placental membrane infection was 
more frequent among HIV positive women and highest among those who 
delivered preterm [6]. 
 
It has also been suggested that the AIDS disease process somehow leads to an 
increase in cytokine levels in the amniotic fluid, which in turn induces preterm 
contractions. In a study conducted by Figueroa, et al. [7], amniocentesis was 
performed on 52 women with preterm labour and intact membranes. The fluid 
was cultured and tested for interleukins with sensitive and specific enzyme-linked 
immunosorbent assays (Table 1). 
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TABLE 1 – Summary of the results of the study of Figueroa, et al. [7] on the 
relevance of intra-amniotic cytokine levels to preterm labour. 
 
Delivered within 7 days of 
amniocentesis 
Undelivered 7 days after 
amniocentesis 
Women 
(N=52) 
32 (62%) 20 (38%) 
Amniotic 
fluid cultures 
Positive Negative Positive Negative 
 9 (28%) 23 (72%) 0 (0%) 20 (100%) 
Cytokine 
levels 
Very high High Low Low 
 
Sixty two percent of women delivered within seven days of amniocentesis and of 
those, 28% had positive cultures. Those that delivered within seven days had 
significantly higher levels of interleukin-1alpha, interleukin-6 and interleukin-8 
than the women who delivered after seven days, regardless of culture results. 
Cytokine levels were higher among women who had positive amniotic fluid 
cultures than those who had negative cultures, but as a group their levels were 
higher than the women who delivered after seven days. 
 
Another study, also from the USA, found a similar association between elevated 
cord and/or placental interleukin-6 and interleukin-8, and preterm delivery and 
chorioamnionitis [8]. 
  
Bodkin, et al. [4] conducted a study at a public sector hospital in Johannesburg, 
to compare maternal and fetal outcomes between HIV positive and HIV negative 
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women. Among their findings was the significant likelihood that HIV positive 
women had a greater chance of having intrauterine fetal growth restriction, earlier 
delivery and smaller babies than HIV negative women. The average gestational 
age at birth for the HIV positive women in their study was 37.92 weeks. This 
value does not represent preterm delivery as such, but was significantly lower 
than the 38.5 weeks for the HIV negative group (37.9 vs. 38.5 weeks, P=0.03). 
 
2.2 Spontaneous miscarriage 
It has been debated for some time whether HIV infection has an effect on fetal 
wastage. In some studies this finding was confirmed. At the Baylor College of 
Medicine it was found that miscarriage was three times more likely among HIV-
infected women than their HIV-uninfected counterparts [9]. The typical rate 
quoted in this publication for non-HIV-infected women was less than three 
percent (for second trimester miscarriages). One hundred and twenty four HIV-
infected women were studied and more than 11% had miscarried in the second 
trimester. Four possible causes listed for this finding of increased risk of spon-
taneous miscarriage among HIV-infected women were: HIV toxicity to the fetus, 
fetal thymic dysfunction, placental changes and elevated uterine levels of 
interleukin-4, interleukin-6 and tumour necrosis factor [9]. 
 
In Nairobi, in a case control study, 13.8% HIV-infected women suffered 
spontaneous miscarriage versus 6.2% of HIV-uninfected women. This indicates 
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that HIV infection was significantly associated with a higher incidence of 
spontaneous miscarriage (p=0.02) [10]. 
 
Several other studies have found similar trends among HIV-infected women, 
which bring to mind the question as to exactly what causes these trends. HIV and 
AIDS obviously have far-reaching effects that are poorly understood and need 
further investigation.  
 
2.3 Fetal outcome 
As seen in studies in other parts of the world, fetal outcome worsens as HIV 
infection progresses to AIDS and the condition of the mother deteriorates.  
 
It is evident that HIV infection has real implications for the fetus of the HIV 
positive mother. A systematic review and meta-analysis of 31 studies was done 
by Brocklehurst and French in Oxford, in the UK [11]. The authors found an 
association between maternal HIV infection and adverse neonatal outcome, 
although the association was not strong. It also appeared that the association 
was stronger for studies done in developing countries such as Kenya, India and 
Pakistan. The adverse outcomes included spontaneous miscarriage, stillbirth, 
fetal abnormality, perinatal death, neonatal death, infant death, intrauterine 
growth restriction, low birth weight and preterm delivery.  
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In a study done in Zaire, a similar picture emerged. The neonatal death rate in 
infants of seropositive mothers was considerably higher than in the group of 
infants born to seronegative women [12].  
 
South Africa, like many countries in the world, has a policy of providing 
antiretroviral drugs to pregnant HIV positive mothers, in an attempt to at least 
prevent the infants from being infected with HIV, even if the mother cannot be 
cured.  
 
More or less a third of babies born to HIV-infected mothers, irrespective of 
maternal health and gestation, will also be infected with HIV if no preventative 
measures are taken [13]. It is thought that most infections occur in the 
intrapartum period and that a further set of infants contract the virus through 
breastfeeding. It has been established that a trustworthy predictor of 
transmission from mother to fetus is viral load, which in turn is a reflection of 
maternal health. Modified obstetric practices, like delay of rupture of membranes, 
elective caesarean section and vaginal cleansing, may reduce the risk of vertical 
transmission of HIV, but antiretroviral treatment is proven to have the greatest 
effect in this regard [13]. 
 
Nevirapine, a non-nucleoside reverse transcriptase inhibitor, is widely used in 
South Africa. Mothers in labour take a single dose of 200 mg approximately six 
hours before the expected time of delivery and the neonate is also given a single 
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dose of 2 mg/kg body weight within 24 to 72 hours of delivery. This regimen has 
been shown to reduce intrapartum vertical transmission by up to 47% [14]. 
 
2.4 Maternal outcome 
It seems that the pregnant state, in turn, has a detrimental effect on the health of 
the HIV-infected mother and indeed speeds up the progress of the disease. 
 
From 1992 to 1996 Kumar, et al. [5] recruited 71 tribal women from Manipur, 
India. Of these, 32 were pregnant, the others not. The subjects were matched for 
age, parity, CD4 lymphocyte count and demographic characteristics. The women 
all had AIDS, stage three or four (WHO clinical staging of HIV disease, Table 3) 
[15]. In the pregnant group, 15 patients contracted Pneumocystis jeroveci 
pneumonia (PCP), of whom 12 died. Three patients died soon after medical 
termination of pregnancy, seven in the third trimester of pregnancy, and two in 
the immediate postpartum period. In the non-pregnant group four patients died of 
PCP. In the pregnant group six more patients died undelivered – five from 
tuberculosis and one from wasting syndrome. In total, 18 of the pregnant patients 
passed away within 17 months of falling pregnant. Fourteen patients delivered 
preterm. Eleven of the premature infants died within six weeks of birth. 
Prematurity and the clinical diagnosis of an AIDS-defining illness was the cause 
of death in nine of these infants. Only 10 of the 39 non-pregnant patients died 
during the course of the study. The 29 surviving non-pregnant patients seemed 
reasonably well at the end of the study (at 42 months follow up). The mean 
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survival time, from the start of the study, for the pregnant mothers who died was 
9.72 months and for the non-pregnant group 22.6 months. This study showed 
that not only does maternal and fetal outcome deteriorate as the disease 
progresses, but also that pregnancy has a considerable influence on the course 
of the disease. 
 
A systematic review of the literature and meta-analysis done by French and 
Brocklehurst [16], investigated the effect of pregnancy on disease progression 
and survival in woman infected with HIV (Table 2). 
 
The women in the review were all pregnant and were compared to a control 
group of women infected with HIV that were not pregnant. Seven studies were 
included in the review. The results showed that pregnant HIV-infected women 
were more likely to experience some deterioration in the HIV disease, progress 
to have an AIDS defining illness, die, or their CD4 count decrease below 200 x 
106/ℓ than HIV-infected women that were not pregnant. These findings only show 
a trend, as most of the associations were not statistically significant. This trend 
was shown to be more pronounced in developing countries. The statistics follow 
in Table 2. 
 
As seen in these two papers, especially in advanced HIV disease, pregnancy can 
have an adverse effect. This effect depends on the stage of the disease at the 
onset of the pregnancy and can vary from progression to AIDS to death. 
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TABLE 2 – Summary of results of the review and meta-analysis done by 
French and Brocklehurst [16]. 
Adverse maternal outcome 
related to HIV infection and 
pregnancy 
Summary odds ratio Confidence interval 
Death 
 
1.8 85%; 0.99 – 3.3 
HIV disease progression 
 
1.41 95%; 0.85 – 2.33 
Progression to AIDS-defining 
illness 
1.63 95%; 1.00 – 2.67 
Fall of CD4 count to below 200 
x 106/ℓ 
0.73 95%; 0.17 – 3.06 
 
In New York, USA, it was found that PCP is the most common cause of AIDS-
related death in pregnant women in the United States. Ahmad, et al. [17] 
reviewed 22 cases of patients with PCP in pregnancy. Thirteen patients de-
veloped respiratory failure and had to be mechanically ventilated. Of the 
ventilated patients only 31% survived. The overall mortality rate was 50%. This 
rate is much higher than those quoted for the general HIV positive population for 
PCP mortality. The conclusion was that PCP has a more aggressive course in 
pregnancy with poor maternal and fetal outcomes [17]. 
 
In Africa, tuberculosis is probably the most common opportunistic infection 
among HIV-infected patients. As the CD4 count falls, the risk of tuberculosis 
increases. However, tuberculosis can occur at any level of CD4 count. In 2000, it 
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was estimated that 50% of patients with tuberculosis in South Africa were also 
HIV positive [18]. Tuberculosis in HIV positive patients is difficult to diagnose, 
because the acid-fast bacilli smears are frequently negative and extra-pulmonary 
tuberculosis is more common. Tuberculous meningitis is seen more often. If a 
patient presents with pulmonary tuberculosis, the shift is away from the classical 
apical, cavitating presentation, towards a more widespread non-specific mid- and 
lower-zone infiltrate that mimics other conditions such as community acquired 
pneumonia and PCP [18].   
 
The fact that tuberculosis presents more commonly as an opportunistic infection 
in the HIV-infected mother, has also been observed in a study in Lusaka, 
Zambia. In 1996 and 1997, 251 maternal deaths were recorded at the University 
Teaching Hospital in Lusaka. The different causes of deaths were as follows: 
1) Direct causes (Obstetric causes)   106 (42%) 
2) Indirect Causes (Non-obstetric causes)  145 (58%) 
o Malaria    30% 
o Tuberculosis    25% 
o Unspecified chronic respiratory  
tract infections   22% 
Ninety two percent of the patients who died of tuberculosis were also HIV-
infected, as well as 97% of the patients that died of unspecified chronic 
respiratory tract infections. The maternal mortality ratio at this hospital increased 
from 118/100 000 live births in 1982 to 921/100 000 in 1997. The author of this 
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publication stated that urgent attention should be paid to the timely diagnosis of 
AIDS-related tuberculosis in pregnancy [19]. 
 
2.5 AIDS – acquired immunodeficiency syndrome 
The face of medicine has changed considerably with the emergence of HIV and 
AIDS, and related diseases. It is sometimes difficult to recognise the different 
ways the disease can present itself. Therefore, the World Health Organisation 
has created a clinical classification system to facilitate management of HIV 
positive patients [15]. 
 
With the use of this classification system, it is easy to establish in which stage of 
the disease the patient is, and which treatment to start. This system is also of use 
in managing the antiretroviral treatment rollout programme that was initiated by 
the SA Government on 8 August 2003 [20]. 
 
The following tables are directly quoted from the WHO Case definitions of HIV for 
surveillance and revised clinical staging and immunological classification of HIV-
related disease in adults and children (2006) [15]. 
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TABLE 3 - Clinical staging of HIV disease (World Health Organization –    
2006) 
CLINICAL STAGE 1 
Asymptomatic 
Persistent generalised lymphadenopathy 
CLINICAL STAGE 2 
Unexplained moderate weight loss (<10% of presumed / measured body 
weight) 
Recurrent respiratory tract infections (sinusitis, tonsillitis, otitis media, 
pharyngitis) 
Herpes zoster 
Angular cheilitis 
Recurrent oral ulceration 
Papular pruritic eruptions 
Seborrhoeic dermatitis 
Fungal nail infections 
CLINICAL STAGE 3 
Unexplained severe weight loss(>10% of presumed / measured body 
weight) 
Unexplained chronic diarrhoea for longer than one month 
Unexplained persistent fever (above 37.5˚C intermittent or constant, for 
longer than one month) 
Persistent oral candidiasis 
Oral hairy leukoplakia 
Pulmonary tuberculosis 
Severe bacterial infections (such as pneumonia, empyema, pyomyositis, 
bone or joint infection, meningitis or bacteraemia) 
Acute necrotizing ulcerative stomatitis, gingivitis or periodontitis 
Unexplained anaemia (<8g/dℓ), neutropaenia (<0.5 x 109/ℓ) and/or chronic 
thrombocytopenia (<50 x 109/ℓ) 
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CLINICAL STAGE 4 
HIV wasting syndrome 
Pneumocystis pneumonia (PCP) 
Recurrent severe bacterial pneumonia  
Chronic herpes simplex infection (orolabial, genital or anorectal of more      
than one month’s duration or visceral at any site) 
Oesophageal candidiasis (or candidiasis of trachea, bronchi or lungs) 
Extrapulmonary tuberculosis 
Kaposi’s sarcoma 
Cytomegalovirus infection (retinitis or infection of other organs) 
Central nervous system toxoplasmosis 
HIV encephalopathy 
Extrapulmonary cryptococcosis including meningitis 
Disseminated non-tuberculous mycobacterial infection 
Progressive multifocal leukoencephalopathy 
Chronic cryptosporidiosis 
Chronic isosporiasis 
Disseminated mycosis (extrapulmonary histoplasmosis or 
coccidiomycosis) 
Recurrent septicaemia (including non-typhoidal Salmonella) 
Lymphoma (cerebral or B-cell non-Hodgkin) 
Invasive cervical carcinoma 
Atypical disseminated leishmaniasis 
Symptomatic HIV-associated nephropathy or symptomatic HIV-associated 
cardiomyopathy 
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2.6 Antiretroviral treatment for preservation of general health in 
HIV-infected patients 
As it is now policy in many countries in the world to provide antiretroviral 
treatment to AIDS sufferers, the question still remains when and how to start this 
treatment. 
 
Severe, et al. [21] conducted a study in Haiti on 1004 HIV-infected patients with a 
median CD4 count of 131 x 106/ℓ. Three drugs were used. The patients were 
followed up for 14 months and according to a Kaplan-Meier analysis 87% of 
adults were still alive at the end of the period. After 12 months, the median 
increase in CD4 count was 163 x 106/ℓ. A decrease in viral load was also 
demonstrated [21]. In the last mentioned study, the findings indicated an 
improvement in the condition of the subjects on treatment. 
 
However, in other studies it has been demonstrated that initiation of treatment 
after the CD4 count has fallen below 200 x 106/ℓ, results in worse outcomes than 
when treatment is started at a higher count. At Montefiore Medical Centre and 
Lincoln Medical and Mental Health Centre in Bronx, New York, USA [22], 1054 
HIV-infected women were recruited in a study to determine the time interval from 
initiation of highly active antiretroviral treatment to development of AIDS and 
death. 
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TABLE 4– Results for the study of Anastos, et al. [22], summarised 
CD4 
Counts    
(x 106/ℓ) 
Relative hazards 
for progression 
to AIDS 
Confidence 
interval 
(95%) 
Relative hazards 
for progression 
to death 
Confidence 
interval 
200 – 350 0.92 0.46-1.86 1.97 0.84-4.66 
< 200 2.48 1.39-4.42 3.35 1.59-7.08 
 
As seen in Table 4, women with lower CD4 counts at initiation of antiretroviral 
treatment had a much higher risk of developing AIDS and dying, as compared 
with women with higher CD4 counts (more than 350 x 106/ℓ).  Also, the lower the 
CD4 count at initiation of treatment, the higher the risk of progression to death 
[22]. 
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3. Subjects and methods 
 
This was a retrospective descriptive study. The Maternity unit at Chris Hani 
Baragwanath Hospital in Soweto, Gauteng, South Africa, was chosen for the site 
of this study. The maternal death files for the years 1990 to 2005 were kept 
separate from the usual record stores and were easy to locate for research 
purposes. 
 
All files of patients that had evidence of AIDS, as defined by a CD4 count below 
200 x 106/ℓ or an AIDS-defining illness that died undelivered or within 42 days of 
delivery or miscarriage, were included in the study. A data sheet was compiled to 
collect information from the files. This data sheet is attached as Appendix A. 
Information such as parity, gravidity, gestational age at delivery, cause of death, 
birth weight of the neonate and antenatal history were extracted from the files. 
The data was summarised by means of tabulation, analysed and then interpreted 
to reach a rational conclusion. 
 
The statistical method used, was descriptive including calculation of totals by 
addition of figures, calculation of frequencies, with percentages, means with 
standard deviations, and medians with ranges. Calculations and tabulations were 
done using Microsoft Excel software. 
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Prior to the commencement of the study, approval to perform the study was 
granted by the Chief Executive Officer of Chris Hani Baragwanath Hospital and 
the University of Witwatersrand Human Research Ethics Committee [Appendix 
B]. 
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4. Definitions 
 
 
The following fundamental terminology was used throughout the paper and some 
clarity on the precise meaning of each phrase is necessary. 
 
 4.1    Maternal death 
A maternal death is defined as the death of a woman while pregnant or 
within 42 days after delivery, miscarriage, termination or other loss of a 
pregnancy. 
 
4.2 AIDS – acquired immunodeficiency syndrome 
In this study, for a patient to be classified as having ‘AIDS-related 
complications’ there would have to be:  
1) A positive HIV result 
AND 
2) The presence of an AIDS-defining illness (WHO Classification, Stage 
IV, refer section 2.5)                                                                                                                                                                                                                                                                                                                       
OR  
      A CD4 count of less than 200 x 106/ℓ. (Refer section 4.8)  
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4.3 Preterm labour 
Preterm labour is defined as the onset of true labour - painful contractions 
accompanied by cervical changes - before the gestational age of 37 
completed weeks [23].  
 
4.4 Term pregnancy 
A term pregnancy is a pregnancy that proceeds to between 37 completed 
and 42 weeks of gestation. A fully developed and normal neonate should 
be the product of such a pregnancy. 
 
4.5     Viable pregnancy 
In this study, a viable pregnancy was considered as a gestation of 26 
completed weeks and more or a fetal birth weight of 900 g and more. This 
definition is used, because some neonatal units in the public sector in 
South Africa use these values as cut-off points for qualification for 
ventilation in neonatal intensive care units. Financial and technological 
constraints result in this limitation on the size of babies these units are 
able to manage. 
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4.6     Low birth weight 
Low birth weight is considered as a birth weight less than 2500 g, 
regardless of the gestational age [24]. 
 
4.7     Intrauterine growth restriction 
Intrauterine growth restriction is diagnosed when the fetal birth weight is 
below the tenth percentile for gestational age in weeks or abnormal growth 
parameters are found on detailed ultrasound scan [24]. 
 
4.8     Helper T-lymphocytes (CD4 count) 
The CD4 count is the number of helper T-lymphocytes in a cubic 
millimetre of blood. As HIV infection progress, the CD4 count decreases, 
and when it falls below 200 x 106/ℓ, the disease is in the AIDS phase. The 
normal value is around 1000 x 106/ℓ. A T-lymphocyte is a subtype of 
leucocyte (white blood cell) [24]. Hereafter helper T-lymphocytes levels in 
this paper will be referred to as CD4 counts.  
 
4.9     Pneumocystis jiroveci pneumonia (PCP) 
Pneumocystis carinii pneumonia is commonly referred to as PCP in the 
medical realm. It is noted that the causal organism underwent a name 
change recently from Pneumocystis carinii to Pneumocystis jiroveci to give 
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credit to the scientist who discovered the organism. The organism will be 
named accordingly in this paper, but for the sake of consistency the 
disease caused by the organism will, for the remainder of the paper, be 
referred to as PCP [25].  
 
4.10 Delivered and undelivered 
Patients whose babies were born before the time of death will be referred 
to as ‘delivered’ and those patients whose babies were not born before the 
time of death, thus dying in utero, will be referred to as ‘undelivered’. 
  
4.11 Neonate and neonatal period 
A neonate is the term used for a newborn baby in the first 28 days of life, 
hence, the neonatal period is also the first 28 days of life. The early 
neonatal period refers to the first 7 days of life [23]. 
 
4.12 Synonyms for an HIV positive result 
In this paper several synonyms are used all indicating a positive HIV 
serology test: HIV-infected, HIV reactive, seropositive, HIV positive. 
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5. Results  
5.1 Study subjects 
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FIGURE 1 – Bar chart showing HIV-related maternal deaths per year at 
Chris Hani Baragwanath Hospital from 1990 to 2005. 
 
The files of 74 patients were found. The dates of HIV-related maternal deaths 
range between January 1990 and December 2005. The mean age at death was 
28.2 years, with the youngest patient 18 years of age and the oldest 40 years 
old. The national prevalence of HIV infection in 1990 was estimated at 0.8% from 
the attendance of antenatal clinics by national survey. This had increased by the 
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end of 2000 to 24.9% [26]. The results obtained in this study are therefore in 
keeping with the national figures of increase in HIV infection and ultimately HIV-
related deaths as seen by the increase in numbers of deaths in the later years in 
this study. 
 
5.2 CD4 counts and antenatal history of the research subjects 
All patients included in the study were recorded to have a reactive HIV test. It is 
not compulsory to have an HIV test at an antenatal clinic, but it is offered to all 
mothers, together with counselling. 
 
Regarding the status of HIV infection, the patients whose CD4 counts were 
available had low counts, the mean being 45.5 x 106/ℓ. Only 49 patients had a 
CD4 count available, despite lengthy hospitalisation periods. In a number of the 
cases that had no results, the test appeared to have been done, but the result 
could not be found. In earlier years, the test was rarely requested, probably 
because of lack of knowledge about HIV/AIDS or expense of the test at that time. 
 
Fifty nine patients attended antenatal clinic and 15 patients did not. The mean 
number of antenatal visits was 4.01. The mean parity was 1.24 and the mean 
gravidity was 2.32. Syphilis serology testing revealed three infected and 50 
uninfected patients, and 21 whose results were not available.  
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5.3 AIDS-related causes of deaths  
The causes of deaths were diverse but a clear trend towards respiratory 
diseases was evident. (Table 5) 
 
A large portion of the study subjects, 55 (74.3%), died of respiratory causes 
directly linked to their HIV status. This number consists of three contributors: 
PCP: 17 (23.0%), community-acquired pneumonia: 16 (21.6%) and pulmonary 
tuberculosis: 22 (29.7%). The second apparent group of causes were the central 
nervous system group at 15.0% (11), consisting of tuberculous meningitis: 5 
(6.8%), cryptococcoma: 3 (4.1%) and bacterial meningitis: 3 (4.1%). Therefore, 
the respiratory and central nervous system causes together accounted for 89.2% 
(66/74) of the maternal deaths. 
 
Patients were accepted into the PCP classification following documented 
therapeutic treatment for PCP, chest x-ray picture or clinical picture suggesting 
PCP. None of the patients had microbiological evidence of PCP, due to the 
difficulties in obtaining positive results from sputum, or doing bronchoscopic 
washings. 
 
The diagnosis of cerebral cryptococcoma was made by computerised 
tomography scan and lumbar puncture. With meningitis, lumbar punctures were 
done and positive results for viral, bacterial or fungal meningitis were obtained. 
Patients classified as having ‘pneumonia’ had a lower respiratory infection, but 
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the infective organism was rarely identified. These patients most probably had 
some community acquired pneumonia, but might have had either PCP or 
tuberculosis. 
 
TABLE 5 - Causes of death in HIV related maternal mortalities at Chris Hani 
Baragwanath Hospital from 1990 to 2005. (n=74)  
Cause Number Percentage 
Postpartum haemorrhage 1 1.4 
Tuberculosis Meningitis 5 6.8 
AIDS – wasting syndrome 2 2.7 
PCP 17 23.0 
Meningitis 3 4.1 
Cryptococcoma 3 4.1 
Pulmonary tuberculosis 22 29.7 
Community-acquired Pneumonia 16 21.6 
Puerperal sepsis 3 4.1 
Malaria 1 1.4 
Kaposi sarcoma 1 1.4 
 
Three patients had postpartum sepsis (‘puerperal sepsis’) as cause of death and 
eventually one had a subtotal hysterectomy. Two more patients had postpartum 
sepsis as complication, but died of other causes (Table 6). One patient had been 
diagnosed with malaria, acquired in another African country. She had advanced 
AIDS and died undelivered.  
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5.4 Obstetric complications 
There was a high incidence of preterm labour and miscarriages among the 
patients studied (Table 6). Most patients experienced more than one com-
plication, with the result that the number of complications did not add up to 74. 
Each complication is separately reflected as a percentage of the patients who 
experienced the complication in relation to the total number of patients. 
 
Forty three patients (58.1%) experienced spontaneous preterm labour. Some 
received tocolytic drugs, but eventually 39 patients delivered premature infants. 
Ten pregnancies (13.5%) ended in miscarriage. 
 
A total of 49 (66.2%) pregnancies ended preterm. This figure is obviously 
significantly more than for the general population. From the data, there is no 
clear cause other than terminal illness and, in most cases, additional infection 
elsewhere in the body. Only one case of chorioamnionitis (1.4%) and four cases 
of preterm prelabour rupture of membranes (5.4%) were diagnosed. However, 
the clinicians did not make a specific search for chorioamnionitis in most of these 
pregnancies. 
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TABLE 6 – Obstetric complications documented in HIV-related maternal 
deaths at Chris Hani Baragwanath Hospital from 1990 to 2005 
Complication Patients Percentage 
Preterm labour 43 58.1 
Fetal distress 10 13.5 
Intrauterine growth restriction 6 8.1 
Intrauterine fetal death 6 8.1 
Pre-eclampsia 2 2.7 
Preterm prelabour rupture of membranes 3 4.0 
Induction of labour 4 5.4 
Postpartum sepsis 5 6.7 
Retained products 9 12.1 
Miscarriage 10 13.5 
Breech presentation 3 4.0 
Cephalopelvic disproportion 1 1.4 
Assisted delivery 2 2.7 
Sub/total hysterectomy 2 2.7 
Hysterotomy 1 1.4 
Placenta accreta 1 1.4 
Chorioamnionitis 1 1.4 
Anhydramnios 2 2.7 
Thrombotic thrombocytopaenic purpura 1 1.4 
Post-partum haemorrhage 4 5.4 
Uterine scar dehiscence 1 1.4 
Abruptio placentae 1 1.4 
 
One case each of placenta accreta, thrombotic thrombocytopaenic purpura, 
chorioamnionitis, uterine scar dehiscence and abruptio placentae (1.4% each) 
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were documented. These four conditions are not thought to be related to HIV or 
AIDS.  
 
Death followed on average 7.9 days after delivery, in those patients who gave 
birth. 
 
TABLE 7 – Mean CD4 counts for the major groups of obstetric 
complications 
Condition Number 
Number with known 
CD4 count 
Mean CD4 count 
± SD 
Preterm labour 43 29 47.3 ± 42.1 
Miscarriage 10 6 34.5 ± 16.8 
Obstetric infection 5 5 75.0 ± 73.0 
Other obstetric compli-
cations 
16 12 29.6 ± 21.4 
 
In the preceding table it can be noted that the lowest mean CD4 counts were 
found in patients that suffered miscarriages and other obstetric complications. 
Due to the low numbers in this study, it is difficult to demonstrate a plausible 
trend. 
 
Six fetuses (8.1%) were diagnosed with intrauterine growth restriction and six 
(8.1%) died in utero. Fetal distress was documented in 10 cases. Not all patients 
were in labour at the time of this finding and not all were medically fit for 
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caesarean section. Thus, in view of poor maternal condition in some cases, the 
fetus was allowed to die in utero in order to try and prolong the mother’s life. 
Hence, a total of 22 fetuses (43.1% - 22/51 viable pregnancies) had some insult 
in the uterus. 
  
5.5 Fetal outcome 
Of the 74 patients studied, 13 died undelivered (17.6%), 10 had miscarriages 
(13.5%) and 51 delivered viable fetuses (68.9%). Fourteen babies were stillborn. 
Of 37 babies that were born alive, six died during the early neonatal period. 
Therefore, only 31 (60.8%) neonates of the possible 51 viable deliveries survived 
the early neonatal period. The 13 fetuses that were undelivered at the time of the 
death of the mother were all alive at the time of the simultaneous death. The 
average gestational age of these babies was 27.9 weeks. 
 
TABLE 8 – Comparison of fetal outcome associated with respiratory and 
other infections 
Outcome Respiratory infections Other infections 
Undelivered (N=13) 8 (61.5%) 5 (38.5%) 
Miscarriage (N=10) 10 (100%) 0 (0%) 
Stillbirth (N=14) 9 (64.3%) 5 (35.7%) 
Early neonatal death (N=6) 3 (50%) 3 (50%) 
Preterm delivery (N=43) 28 (65.1%) 15 (34.9%) 
Surviving infant (N=31) 21 (67.7) 10 (32.3%) 
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It should be noted that in all categories of fetal outcome, maternal respiratory 
disease was more prevalent than other infections. 
 
The mean birth weight of neonates delivered was 1698 g, with the lowest weight 
900 g and the highest 2950 g (among the viable fetuses). A total of 36 babies 
where the weight was known had a low birth weight. Only three neonates had a 
birth weight above 2500 g. In 13 babies the weight was unknown. The average 
gestational age at birth was 30.5 weeks. This very low figure has implications on 
the health system as premature infants need special care in order to survive, 
sometimes at considerable cost.  
 
Fourteen deliveries were by caesarean section (27.5%). Two vaginal deliveries 
were assisted due to poor maternal health. There were two sets of twins, whose 
mothers both died undelivered. Sex was equally distributed among the neonates 
at 51% female and 49% male.  
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6. Discussion  
 
 
The aim of the study was to identify a trend towards specific obstetric 
complications among terminally ill patients with AIDS. Preterm labour and early 
pregnancy losses were unusually common. In addition, fetal outcome was poor, 
with a high perinatal mortality rate. 
 
6.1     Preterm labour 
It has been suggested in the literature that preterm labour may occur secondary 
to intrauterine infection. 
 
If it is true that preterm labour is most likely caused by chorioamnionitis, then the 
more advanced the stage of HIV infection, the greater the chances of having 
preterm labour. This suggests that a large proportion of these women may have 
chorioamnionitis, even if it was sub-clinical. 
 
In this study, over half of these women experienced preterm birth. Considering 
the preceding discussion, it seems clear that women in the terminal stages of 
AIDS, with various associated infectious conditions, are at risk for preterm labour. 
The average CD4 count was 45.5 x 106/ℓ, predisposing these women to severe 
infections, most likely to cause cytokine release, in turn leading to uterine 
contractions, and preterm labour.  
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6.2     Spontaneous miscarriage 
It was observed during the data collection for this paper that a high number of 
patients (10/74 - 13.5%) experienced spontaneous miscarriage. This number is 
higher than expected when compared to the general HIV negative population.  
 
Many papers published also indicated a higher rate of miscarriages among the 
HIV positive subjects of their studies. It leaves the question whether HIV testing 
should be done routinely as investigation of the cause of miscarriage and not 
only in later pregnancy for the prevention of HIV transmission from mother to 
child.  
 
The mechanism for the increased miscarriage rate among HIV-infected mothers 
is unclear. It could be that the same process that ends viable pregnancies 
prematurely, is responsible for miscarriage. 
  
6.3 Fetal outcome 
In this study, only 60.8% (31/51) of viable pregnancies resulted in a live infant 
past the first seven days of life. 
 
A very large contributing factor to the unusually high perinatal mortality rate is the 
large group of preterm deliveries in this study group. Many infants died in the 
neonatal period due to prematurity. It could not be determined whether some of 
them died directly as a result of HIV infection. There was also a high stillbirth 
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rate. The exact cause of this could not directly be deduced from the information 
in the files, but if one considers the high incidence of fatal maternal respiratory 
disease, hypoxia could have played a role in the death of these fetuses.   
 
The follow-up period for infants in this study was short due to the retrospective 
nature of the data collection and relatively poor record keeping in some of the 
files. It is therefore impossible to say what the long term outcome and in 
particular the incidence of transmission of HIV from mother to child was. The 
possible infant death rate in the study group could have been even higher if this 
information had been available. 
 
The average gestational age at birth (30.5 weeks) and relatively low birth weights 
are in keeping with the findings of research done elsewhere. It could be said, 
however, that the more advanced the disease, the more likely preterm delivery 
and intrauterine growth restriction will be. Obviously, in view of the high incidence 
of prematurity in this group, the perinatal mortality rate would be much higher 
than in healthier patients where the mean gestational age at birth would be 
slightly higher.  
 
In the calculation of the mean birth weight in the results of this paper, the number 
is artificially low, because so many preterm deliveries occurred. During the 
capturing of data, it was however noted that term neonates also often had low 
birth weights. This could be due to the general poor health of the mothers, poor 
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nutritional status, pathology in the placenta or some metabolic process in the 
body of the mother.  
 
Another alarming finding was the frequent finding of fetal distress documented. 
Over 13% (10/74) of fetuses had distress with or without labour. Some babies 
could clearly not withstand the stress of labour and those that experienced 
distress out of labour apparently suffered some insult relating to maternal 
disease. They may have been hypoxic secondary to maternal disease, but this 
could not be validated due to the retrospective nature of the study. 
 
6.4 Maternal outcome 
Maternal outcome in this study was, by definition, dismal. As stated in the title of 
the paper, all subjects died. All patients were severely immuno-suppressed, as 
reflected by low CD4 count or the presence of an AIDS-defining illness.  The 
maternal outcome in this research can evidently not be generalized, as these 
patients were selected for the fact that they died within 42 days of delivery or still 
being pregnant when they died. The trend towards certain causes of deaths is 
worthy of discussion. 
 
In this study, 74.3% of study subjects died of pulmonary causes (Table 5). This is 
not surprising when a careful literature study is conducted, as similar findings 
have been reported elsewhere [17, 18, 19]. 
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The other large group of mortalities (15%) could be assigned to central nervous 
system causes. This complication is common in patients with AIDS.  
 
Pregnant patients are clearly at risk of contracting severe pulmonary or central 
nervous system infections.  Aggressive prevention and treatment of these 
conditions should be a priority in pregnant patients with AIDS. Although co-
trimoxazole and anti-TB treatment are routinely given to confirmed cases of PCP 
and tuberculosis, thought should be given to aggressive prevention with 
prophylactic doses of cotrimoxazole e.g. two tablets Bactrim daily. Clinicians 
should actively be on the look-out for respiratory and nervous system infection in 
HIV positive pregnant patients. 
 
6.5 AIDS – acquired immunodeficiency syndrome 
HIV infection is on the increase in South Africa. There is a noticeable increase in 
yearly incidence of AIDS-related maternal deaths with no deaths in some years 
in the early nineties, up to 20 deaths in 2004 (Figure 1). Thus, almost 2 patients 
per month died in 2004.  
 
A lack of proper investigation of HIV positive patients was seen in the files of 
patients in the earlier years of the investigation. CD4 counts were not requested 
or the results were not obtained and documented in the files. This finding can 
indicate that the understanding of the disease in the early nineties was wanting, 
but improved in the years that followed. As more patients with HIV infection and 
 37 
AIDS presented, clinicians became more experienced in managing these 
patients.  
 
6.6 Antiretroviral treatment for preservation of general health in 
HIV-infected patients 
With a study such as this demonstrating the need for effective treatment for 
general health and some improvement in life expectancy, the necessity of 
antiretroviral treatment is evident. Even though data is insufficient, studies like 
those conducted by Severe, et al. [21] and Anastos, et al. [22] have suggested 
improvement in CD4 counts and survival in patients with AIDS on antiretroviral 
drugs.  
 
In South Africa, it is policy to start treatment at a CD4 count less than 200 x 106/ℓ. 
This may mean that patients in this country have a poorer prognosis because of 
delayed commencement of treatment. Consideration should be given to 
increasing the lower cut off of the CD4 count to 350 x 106/ℓ to qualify for 
antiretroviral treatment [22]. As seen in this study and in research done 
elsewhere in the world, pregnancy speeds up the progress of AIDS. Therefore it 
should be investigated whether pregnant patients should perhaps start 
antiretroviral treatment at even higher CD4 count levels.  
 
The study subjects had an extremely low mean CD4 count and considering the 
fact that all of them died in the peripartum period, one is concerned about 
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patients deteriorating to such poor health if treatment could prevent it. It seems 
that none of the patients of this study were on antiretroviral treatment as no such 
treatment was documented in the files. Therefore it is impossible to comment on 
the effect of such treatment in this particular study. It can only be speculated 
whether antiretroviral treatment, commenced in good time, could have prevented 
some of the deaths in this research project. 
 
6.7 Placental interleukin release in response to hypoxia 
Considering the association between preterm delivery and possible increased 
production of cytokines into the uterine cavity, one needs to investigate the 
possible mechanism of this increased production. Even though the raised 
cytokine levels are associated with infection, other possible mechanisms of 
increased production do exist. 
 
An article by Malek, et al. [27] discusses placental hypoxia and ischaemia in pre-
eclampsia. The effect of hypoxia, oxidative stress and lipopolysaccharides were 
determined on human term placental tissue explants. Prostaglandin and cytokine 
production by the placental tissue in reaction to the hypoxia, oxidative stress and 
lipopolysaccharides were measured. The results concluded that hypoxia had no 
effect on the production of prostaglandins, but interleukin-1beta production 
increased 15 fold. Oxidative stress increased prostaglandin production 15 fold 
and increased cytokine (interleukin-1alpha, interleukin1-beta, interleukin-6 and 
tumour necrosis factor-alpha) production 130 fold.  
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Another study by Benyo, et al. [28] in 1997 reported similar results. The human 
placenta apparently produces increased levels of interleukins under hypoxic 
circumstances. It seems likely that maternal hypoxaemia, resulting from 
pulmonary disease, such as HIV-related pneumonia, could induce a similar 
response in the placenta. The dual outcomes of fetal hypoxia and preterm labour 
would be expected in such circumstances [7]. 
 
This study found that almost 60% of the patients experienced some form of 
preterm delivery, in the apparent absence of infection of the amniotic fluid and 
membranes.  
 
If it is true that a hypoxic state can induce the normal placenta to produce 
pathologically increased levels of cytokines, it is possible that maternal 
hypoxaemia, caused by the pulmonary infection, and not chorioamnionitis, 
resulted in placental production of interleukins, which then induced preterm 
contractions.   
 
Furthermore, almost one third of fetuses had evidence of some hypoxic process 
affecting them, in the form of intrauterine growth restriction, intrauterine fetal 
death or fetal distress with or without labour. 
 
The same can be said of the fact that the same interleukins as seen in the 
studies about preterm labour and hypoxic states of the placenta are also the 
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interleukins which are connected with the mechanism of miscarriages. Therefore 
it can be deduced that the increased incidence of miscarriage can be due to the 
same hypoxic process resulting in the increase of the same interleukins, leading 
to preterm delivery – only at a gestational age where the fetus is not yet viable.  
 
It is impossible to prove that the mechanism suggested is indeed true in the 
context of this study. This theory can only be validated in further research where 
samples of amniotic fluid in a similar study group are tested for interleukin 
content. Simultaneous microscopy and culture of these samples should be done 
to exclude intrauterine infection. In addition, maternal hypoxia would have to be 
present in patients with high interleukin levels in the amniotic fluid to prove this 
suggestion true. 
 
6.8 Reproductive rights of HIV-infected individuals in South Africa 
It is clear that pregnancy probably has an adverse effect on the general health of 
the HIV-infected mother and in some cases also speeds up the progress of the 
disease. The question therefore remains whether such patients have to be 
advised against pregnancy, or even be offered termination.  
 
From an ethical point of view and also regarding this country’s charter of rights, 
the autonomy of the patient should be respected, but informed decisions would 
be the ideal. A planned pregnancy in correlation with the mother’s general health 
and CD4 count, together with counselling about the possible effects of the 
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pregnancy on the disease, should be the aim. Antiretroviral therapy should play a 
key role not only in prevention of mother-to-child-transmission, but also preser-
vation of maternal health in the latter stages of AIDS. 
 
In general, the HIV positive mother should not be denied the right to motherhood 
purely on the basis of her status alone. Cultural aspects are of importance in this 
setting, where a barren woman can easily be excluded from the community and 
abandoned by her husband [29]. 
 
The adverse effect of pregnancy on the progression of HIV disease is reason for 
concern. HIV positive women should ideally be counselled to fall pregnant only 
when in good health and with high CD4 counts. Consideration should be given to 
the possibility of termination of pregnancy for the sake of maternal health when 
these parameters are not met.  
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7. Limitations 
 
The retrospective nature of this study made data collection entirely dependent on 
what was in the notes. Missing and incorrect data proved to be a problem. CD4 
counts, for example, were not always documented despite notes being made of 
the test being done. Because of the long time period researched (16 years), it 
was not always possible to locate information if it was not recorded. 
 
Furthermore, follow-up information on the live-born infants was not available past 
a few days of life. With paediatric care being given in a different department and 
the babies having different files from mothers, it was also impossible to locate 
these children.  
 
A number of maternal deaths do occur in the medical and surgical wards of Chris 
Hani Baragwanath Hospital and these may have been missed. When mothers 
present with serious medical or surgical problems they are sometimes admitted 
in the relevant ward and not in the maternity ward. It also happens that mothers 
are treated elsewhere in the hospital without the pregnancy being noticed initially. 
In such cases treatment is continued in the original wards of admission and the 
obstetricians visit daily to monitor the progress of the pregnancy. There is no 
known mechanism for finding records of such deaths.  Patients who died at home 
could also not be reported here. 
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The definition of AIDS, despite the clear criteria set out above, might not have 
been applied in some patients because of the presence of unresolved and 
untreated pathology. Some patients could not be included in the study, despite 
having clear evidence in the file of being HIV positive, because no clear note was 
made that a test was done or that a result was obtained. 
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8. Conclusion 
 
 
The overwhelming majority of maternal deaths were related to a respiratory 
cause in the form of PCP, tuberculosis and community acquired pneumonia. One 
can assume that pulmonary disease resulting in death will lead to significant 
hypoxaemia. This is well known to have widespread metabolic consequences in 
the body, including acidosis and vasoconstriction.  
 
A large number of fetuses in this research project also displayed evidence of 
possible hypoxia. Fetal distress, as seen on cardiotocograph, intrauterine growth 
restriction and intrauterine death were observed. These phenomena can all be 
traced back to fetal hypoxia – further evidence of an oxygen shortage 
experienced by both mother and child. 
 
A very high proportion of women also had preterm labour. In the preceding 
discussion, evidence was given that could link preterm labour to raised levels of 
interleukins in the amniotic fluid. Previous publications entertained the idea that 
an increase in interleukin levels, in the setting of preterm labour is linked to 
infection. 
 
As reported, the same interleukins that cause preterm labour are also the ones 
that could be responsible for the increased rates of spontaneous miscarriage 
among HIV-infected women. 
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However, it has been proven that hypoxia and oxidative stress can cause the 
placenta to start producing the very same interleukins. The conclusion can 
therefore be made that patients with end stage AIDS, being more prone to 
pulmonary infections and thus to hypoxia, develop preterm labour indeed as a 
result of the production of interleukins into the uterine cavity. The difference is 
that the interleukin production could well be due to the hypoxic state, and not due 
to an infective process.  
 
The implication for the management of the pregnant HIV patient is evident. 
Pulmonary infection should be avoided if possible during pregnancy to prevent 
preterm labour and delivery of a compromised premature infant. It seems, in the 
light of these findings, that aggressive prevention and treatment of PCP and 
tuberculosis are crucial. Patients should also have access to antiretroviral 
treatment to maintain reasonable immune responses. Antiretroviral drugs should 
possibly be offered at higher CD4 counts than 200 x 106/ℓ and prophylactic 
administration of cotrimoxazole should be part of the protocol of any antiretroviral 
regimen. 
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APPENDIX A – Datasheet used to collect information from AIDS-related 
maternal death files at Chris Hani Baragwanath Hospital from 1990 to 2005 
        
                                                                                                                Subject no: ‗‗‗‗‗‗‗‗‗‗‗‗ 
 
Age: ‗‗‗‗‗‗‗‗‗‗      Parity: ‗‗‗‗‗‗‗‗‗‗  Gravida: ‗‗‗‗‗‗‗‗‗‗ 
 
Rh: ‗‗‗‗‗‗‗‗‗‗     RPR: ‗‗‗‗‗‗‗‗‗‗ CD4:  ‗‗‗‗‗‗‗‗‗‗ 
 
Date of admission:  ‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗ 
 
Summary of disease progression: 
 
‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗ 
 
‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗ 
 
‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗ 
 
‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗ 
 
‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗ 
 
GA at delivery/death:  ‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗ 
 
Cause of death:  ‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗ 
 
Date of death:   ‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗ 
 
Obstetric complications: 
 
‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗ 
 
‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗ 
 
‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗ 
 
‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗ 
 
Booked: ‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗ Visits: ‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗ 
 
ANC History: 
 
‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗ 
 
‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗ 
 
Neonatal outcome:    Alive    Dead 
  
‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗‗ 
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APPENDIX B – Ethics approval letter from the University of Witwatersrand 
Human Research Ethics Committee 
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APPENDIX C – Letter to the University of Witwatersrand Human Research 
Ethics Committee stating change of title of the research project and 
surname of researcher 
        1164 Woodlands Drive 
        Queenswood 
        Pretoria 
        0186 
        3 April 2007 
 
Sir/Madam 
 
Human Ethics Committee (Medical) 
University of the Witwatersrand 
Private Bag 3 
Wits 
2050 
South Africa 
 
Particulars regarding the research of Dr Berna Jordaan. 
 
Please note the following about the research that was approved by the 
Committee last year: 
 
1. The title of the paper was changed in guidance of the MMed 
Committee of the University of the Witwatersrand,  Postgraduate office 
from  
• In Maternal Deaths Related to AIDS, Is There a Trend Towards 
Certain Obstetric Complications? 
TO 
• Obstetric Complications in Maternal Deaths Related to AIDS. 
The fundamentals of the research remain exactly the same, only the 
title was changed. 
 
2. My surname has changed as well as my address, as I got married                   
on the 23rd of December 2006. Jordaan was my previous married 
name and I am therefore changing it to my new married name. My 
registration at the HPCSA has also been changed accordingly. I 
include a copy of my marriage certificate. My new surname is Venter. 
 
 
Thank you. 
 
 
 
 
Dr B Venter (082 3388 976) 
